Minerva Neurosciences, Inc.
company in Waltham, United States
NERV Nasdaq
SEC CIK 1598646
Follow Minerva Neurosciences
Weekly email: filings, results, news
Net income
$17.5M
+636% vs same quarter last year
EPS, diluted
−$0.14
+67.4% vs same quarter last year
Operating cash flow
−$13.3M
−553.5% vs same quarter last year
Operating income
−$10.6M
−215.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$293.4M |
| FY24 | $0 | $1.4M |
| FY23 | $0 | −$30M |
| FY22 | $0 | −$32.1M |
| FY21 | $0 | −$49.9M |
| FY20 | $0 | $1.9M |
| FY19 | $0 | −$72.2M |
| FY18 | $0 | −$50.2M |
| FY17 | $0 | −$31.5M |
| FY16 | - | −$31M |
| FY15 | - | −$27.1M |
| FY14 | - | −$56.9M |
| FY13 | - | −$3.3M |
| FY12 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | −$24.7M |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | $3M |
| FY16 | - |
| FY15 | - |
| FY14 | −$36M |
| FY13 | −$2.2M |
| FY12 | - |
News
No stories filed under Minerva Neurosciences yet - coverage appears here as the news feed clusters it.